100 years of Lewy pathology (original) (raw)

• Lewy, F. Paralysis agitans. I. Pathologische Anatomie. In Handbuch der Neurologie Vol. 3 (eds Lewandowsky, M. & Abelsdorff, G.) 920–933 (Springer-Verlag, Berlin, 1912).
  Google Scholar
• Tretiakoff, C. Contribution à l'étude de l'anatomie pathologique du locus niger de Soemmering avec quelques déductions relatives à la pathogénie des troubles du tonus musculaire et de la maladie de Parkinson. Thesis, University of Paris (1919).
  Google Scholar
• Braak, H. et al. Amygdala pathology in Parkinson's disease. Acta Neuropathol. 88, 493–500 (1994).
  CAS PubMed Google Scholar
• Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047 (1997).
  CAS PubMed Google Scholar
• Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
  CAS PubMed Google Scholar
• Satake, W. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303–1307 (2009).
  CAS PubMed Google Scholar
• Simón-Sánchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308–1311 (2009).
  PubMed PubMed Central Google Scholar
• Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197–211 (2003).
  PubMed Google Scholar
• Holdorff, B. Friedrich Heinrich Lewy (1885–1950) and his work. J. Hist. Neurosci. 11, 19–28 (2002).
  PubMed Google Scholar
• Rodrigues e Silva, A. M. et al. Who was the man who discovered the “Lewy bodies”? Mov. Disord. 25, 1765–1773 (2010).
  PubMed Google Scholar
• Sweeney, P. J., Lloyd, M. F. & Daroff, R. B. What's in a name? Dr. Lewey and the Lewy body. Neurology 49, 629–630 (1997).
  CAS PubMed Google Scholar
• Lewy, F. H. Zur pathologischen Anatomie der Paralysis agitans [German]. Dtsch. Z. f. Nervenheilk. 50, 50–55 (1913).
  Google Scholar
• Lafora, G. R. & Glueck, B. Beitrag zur Histopathologie der myoklonischen Epilepsie [German]. Z. ges. Neurol. Psychiat. 6, 1–14 (1911).
  Google Scholar
• Blocq, P. & Marinesco, G. Sur un cas de tremblement parkinsonien hémiplégique symptomatique d'une tumeur du pédoncule cérébral [French]. C. R. Soc. Biol. 5, 105–111 (1893).
  Google Scholar
• Lewy, F. H. Die Lehre vom Tonus und der Bewegung (Springer-Verlag, Berlin, 1923).
  Google Scholar
• Hassler, R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus [German]. J. Psychol. Neurol. 48, 387–455 (1938).
  Google Scholar
• Lewy, F. H. Die Entstehung der Einschlusskörper und ihre Bedeutung für die systematische Einordnung der sogenannten Viruskrankheiten [German]. Dtsch. Z. f. Nervenheilk. 124, 93–100 (1932).
  Google Scholar
• Goedert M., Clavaguera, F. & Tolnay, M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33, 317–325 (2010).
  CAS PubMed Google Scholar
• Lewy, F. H. Historical introduction: the diseases of the basal ganglia. Res. Publ. Ass. Nerv. Ment. Dis. 21, 1–20 (1942).
  Google Scholar
• de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinson's disease. Lancet Neurol. 5, 525–535 (2006).
  PubMed Google Scholar
• Reid, W. G., Hely, M. A., Morris, J. G., Loy, C. & Halliday, G. M. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). J. Neurol. Neurosurg. Psychiatry 82, 1033–1037 (2011).
  CAS PubMed Google Scholar
• Braak, H. & Del Tredici, K. Neuroanatomy and pathology of sporadic Parkinson's disease. Adv. Anat. Embryol. Cell Biol. 201, 1–119 (2009).
  PubMed Google Scholar
• Krüger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106–108 (1998).
  PubMed Google Scholar
• Zarranz, J. J. et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164–173 (2004).
  CAS PubMed Google Scholar
• Goedert, M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2, 492–501 (2001).
  CAS PubMed Google Scholar
• Singleton, A. B. et al. α-Synuclein locus triplication causes Parkinson's disease. Science 302, 841 (2003).
  CAS PubMed Google Scholar
• Chartier-Harlin, M. C. et al. α-Synuclein locus duplication in a case of familial Parkinson's disease. Lancet 364, 1167–1169 (2004).
  CAS PubMed Google Scholar
• Ibanez, P. et al. Causal relation between α-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169–1171 (2004).
  CAS PubMed Google Scholar
• Krüger, R. et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/apolipoprotein E genotype. Ann. Neurol. 45, 611–617 (1999).
  PubMed Google Scholar
• Poulopoulos, M., Levy, O. A. & Alcalay, R. N. The neuropathology of genetic Parkinson's disease. Mov. Disord. 27, 831–842 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kanazawa, T. et al. Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals. Brain Pathol. 22, 67–78 (2012).
  PubMed Google Scholar
• Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149, 1048–1059 (2012).
  CAS PubMed PubMed Central Google Scholar
• Dickson, D. W. et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol. 115, 437–444 (2008).
  PubMed Google Scholar
• Josephs, K. A., Parisi, J. E. & Dickson, D. W. Alpha-synuclein studies are negative in post-encephalitic parkinsonism of von Economo. Neurology 59, 645–646 (2002).
  PubMed Google Scholar
• Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469–6473 (1998).
  CAS PubMed PubMed Central Google Scholar
• Serpell, L. C., Berriman, J., Jakes, R., Goedert, M. & Crowther, R. A. Fibre diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proc. Natl Acad. Sci. USA 97, 4897–4902 (2000).
  CAS PubMed PubMed Central Google Scholar
• Vilar, M. et al. The fold of α-synuclein fibrils. Proc. Natl Acad. Sci. USA 105, 8637–8642 (2008).
  CAS PubMed PubMed Central Google Scholar
• Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160–164 (2002).
  CAS PubMed Google Scholar
• Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant modification of α-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739–29752 (2006).
  CAS PubMed Google Scholar
• Kuusisto, E., Parkkinen, L. & Alazuloff, I. Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J. Neuropathol. Exp. Neurol. 62, 1241–1253 (2003).
  CAS PubMed Google Scholar
• McKeith, I. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863–1872 (2005).
  CAS PubMed Google Scholar
• Kosaka, K. & Manabe, Y. The first autopsied case of diffuse Lewy body disease (DLBD); re-examination by recent immunostaining methods. Neuropathology 30, 458–462 (2010).
  PubMed Google Scholar
• Kotzbauer, P. T., Trojanowski, J. Q. & Lee, V. M. Lewy body pathology in Alzheimer's disease. J. Mol. Neurosci. 17, 225–232 (2001).
  CAS PubMed Google Scholar
• Lee, H. G., Zhu, X., Takeda, A., Perry, G. & Smith, M. A. Emerging evidence for the neuroprotective role of α-synuclein. Exp. Neurol. 200, 1–7 (2006).
  CAS PubMed Google Scholar
• Saha, A. R. et al. Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons. J. Cell Sci. 117, 1017–1024 (2004).
  CAS PubMed Google Scholar
• Beach, T. G. et al. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol. 115, 445–451 (2008).
  CAS PubMed Google Scholar
• Dugger, B. N. & Dickson, D. W. Cell type-specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies. Acta Neuropathol. 120, 633–639 (2010).
  CAS PubMed PubMed Central Google Scholar
• Del Tredici, K. & Braak, H. Spinal cord lesions in sporadic Parkinson's disease. Acta Neuropathol. 124, 643–664 (2012).
  CAS PubMed Google Scholar
• Braak, H., Sastre, M., Bohl, J. R., de Vos, R. A. & Del Tredici, K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 113, 421–429 (2007).
  PubMed Google Scholar
• Wakabayashi, K., Takahashi, H., Ohama, E. & Ikuta, F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol. 79, 581–583 (1990).
  CAS PubMed Google Scholar
• Pouclet, H. et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol. Dis. 45, 305–309 (2012).
  PubMed Google Scholar
• Wakabayashi, K. & Takahashi, H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur. Neurol. 38 (Suppl. 2), 2–7 (1997).
  PubMed Google Scholar
• Fumimura, Y. et al. Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J. Neuropathol. Exp. Neurol. 66, 354–362 (2007).
  PubMed Google Scholar
• Del Tredici, K., Hawkes, C. H., Ghebremedhin, E. & Braak, H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol. 119, 703–713 (2010).
  PubMed Google Scholar
• Iwanaga, K. et al. Lewy body-type degeneration in cardiac plexus in Parkinson's disease and incidental Lewy body diseases. Neurology 52, 1269–1271 (1999).
  CAS PubMed Google Scholar
• Orimo, S. et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 109, 583–588 (2005).
  PubMed Google Scholar
• Ghebremedhin, E., Del Tredici, K., Langston, J. W. & Braak, H. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study. Acta Neuropathol. 118, 777–784 (2009).
  CAS PubMed Google Scholar
• Jellinger, K. A. Pathology of Parkinson's disease. Changes other than in the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153–197 (1991).
  CAS PubMed Google Scholar
• Lang, A. E. & Obeso, J. A. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol. 3, 309–316 (2004).
  PubMed Google Scholar
• Langston, J. W. The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann. Neurol. 59, 591–596 (2006).
  PubMed Google Scholar
• Dickson, D. W. et al. Neuropathology of non-motor features of Parkinson's disease. Parkinsonism Relat. Disord. 15 (Suppl. 3), S1–S5 (2009).
  PubMed Google Scholar
• Lim, S. Y., Fox, S. H. & Lang, A. E. Overview of the extranigral aspects of Parkinson disease. Arch. Neurol. 66, 167–172 (2009).
  PubMed Google Scholar
• Bloch, A., Probst, A., Bissig, H., Adams, H. & Tolnay, M. α-Synuclein pathology of the spinal and peripheral autonomic nmervous system in neurologically unimpaired elderly subjects. Neuropathol. Appl. Neurobiol. 12, 284–295 (2006).
  Google Scholar
• Dickson, D. W., Uchikado, H., Fujishiro, H. & Tsuboi, Y. Evidence in favour of Braak staging of Parkinson's disease. Mov. Disord. 25 (Suppl. 1), S78–S82 (2010).
  PubMed Google Scholar
• Halliday, G., McCann, H. & Shepherd, C. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease? Expert Rev. Neurother. 12, 673–686 (2012).
  CAS PubMed Google Scholar
• Braak, H. et al. Pathology associated with sporadic Parkinson's disease—where does it end? J. Neural Transm. 70, 89–97 (2006).
  Google Scholar
• Uchikado, H., Lin, W. L., De Lucia, M. W. & Dickson, D. W. Alzheimer disease with amygdala Lewy bodies: a distinct form of α-synucleinopathy. J. Neuropathol. Exp. Neurol. 65, 685–697 (2006).
  CAS PubMed Google Scholar
• Saito, Y. et al. Lewy body-related α-synucleinopathy in aging. J. Neuropathol. Exp. Neurol. 63, 742–749 (2004).
  PubMed Google Scholar
• Beach, T. G. et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol. 117, 613–634 (2009).
  PubMed PubMed Central Google Scholar
• Dickson, D. W. et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150–1157 (2009).
  CAS PubMed Google Scholar
• Braak, H., de Vos, R. A., Bohl, J. & Del Tredici, K. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci. Lett. 396, 67–72 (2006).
  CAS PubMed Google Scholar
• Del Tredici, K. & Braak, H. Lewy pathology and neurodegeneration in premotor Parkinson's disease. Mov. Disord. 27, 597–607 (2012).
  PubMed Google Scholar
• Annerino, D. M. et al. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol. 124, 665–680 (2012).
  PubMed PubMed Central Google Scholar
• Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S. & Kordower, J. H. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov. Disord. 27, 716–719 (2012).
  PubMed Google Scholar
• Klos, K. J. et al. α-Synuclein pathology in the spinal cord of neurologically asymptomatic aged individuals. Neurology 66, 1100–1102 (2006).
  CAS PubMed Google Scholar
• Schapira, A. H. & Tolosa, E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat. Rev. Neurol. 6, 309–317 (2010).
  CAS PubMed Google Scholar
• Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14, 501–503 (2008).
  CAS PubMed Google Scholar
• Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B. & Olanow, C. W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14, 504–506 (2008).
  CAS PubMed Google Scholar
• Ahn, T. B., Langston, W. J., Aachi, V. R. & Dickson, D. W. Relationship of neighbouring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease. Am. J. Neurodegener. Dis. 1, 49–59 (2012).
  PubMed PubMed Central Google Scholar
• Li, J. Y. et al. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Mov. Disord. 25, 1091–1096 (2010).
  PubMed Google Scholar
• Greffard, S. et al. A stable proportion of Lewy body-bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death. Neurobiol. Aging 31, 99–103 (2010).
  CAS PubMed Google Scholar
• Prusiner, S. B. A unifying role for prions in neurodegenerative diseases. Science 336, 1511–1513 (2012).
  CAS PubMed PubMed Central Google Scholar
• Parkkinen, L. et al. Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson's disease. J. Parkinsons Dis. 1, 277–286 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hawkes, C. J., Del Tredici, K. & Braak, H. A timeline for Parkinson's disease. Parkinsonism Relat. Disord. 16, 79–84 (2010).
  PubMed Google Scholar
• Neudorfer, O. et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. Q. J. Med. 89, 691–694 (1996).
  CAS Google Scholar
• Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651–1661 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rosenbloom, B. et al. The incidence of parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol. Dis. 46, 95–102 (2011).
  PubMed Google Scholar
• Goker-Alpan, O., Stubblefield, B. K., Giasson, B. I. & Sidransky E. Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders. Acta Neuropathol. 120, 641–649 (2010).
  CAS PubMed PubMed Central Google Scholar
• Westbroek, W., Gustafson, A. M. & Sidransky, E. Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol. Med. 17, 485–493 (2011).
  CAS PubMed PubMed Central Google Scholar
• Paisán-Ruíz, C. et al. Cloning of the gene containing mutations that cause _PARK8_-linked Parkinson's disease. Neuron 44, 595–600 (2004).
  PubMed Google Scholar
• Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601–607 (2004).
  CAS PubMed Google Scholar
• Ross, O. A. et al. Lrrk2 and Lewy body disease. Ann. Neurol. 59, 388–393 (2006).
  CAS PubMed Google Scholar
• Kitada, T. et al. Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608 (1998).
  CAS PubMed Google Scholar
• Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160 (2004).
  CAS PubMed Google Scholar
• Park, J. et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157–1161 (2006).
  CAS PubMed Google Scholar
• Clark, I. E. et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162–1166 (2006).
  CAS PubMed Google Scholar
• Kondapalli, C. et al. PINK1 is activated by mitochondrial membrane depolarization and stimulates Parkin E3 ligase activity by phosphorylating serine 65. Open Biol. 2, 120080 (2012).
  PubMed PubMed Central Google Scholar
• Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell. Biol. 12, 9–14 (2011).
  CAS PubMed PubMed Central Google Scholar
• Bonifati, V. et al. Mutations in the _DJ_-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259 (2003).
  CAS PubMed Google Scholar
• Canet-Avilés, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA 101, 9103–9108 (2004).
  PubMed PubMed Central Google Scholar
• Zarow, C., Lyness, S. A., Mortimer, J. A. & Chui, H. C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60, 337–341 (2003).
  PubMed Google Scholar
• Samaranch, L. et al. _PINK1_-linked parkinsonism is associated with Lewy body pathology. Brain 133, 1128–1142 (2010).
  PubMed Google Scholar
• Papp, M. I., Kahn, J. E. & Lantos, P. L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy. J. Neurol. Sci. 94, 79–100 (1989).
  CAS PubMed Google Scholar
• Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180–182 (1998).
  CAS PubMed Google Scholar
• Spillantini, M. G. et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205–208 (1998).
  CAS PubMed Google Scholar
• Tu, P. H. et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 44, 415–422 (1998).
  CAS PubMed Google Scholar
• Scholz, S. W. et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann. Neurol. 65, 610–614 (2009).
  CAS PubMed PubMed Central Google Scholar
• Al-Chalabi, A. et al. Genetic variants of the α-synuclein gene SNCA are associated with multiple system atrophy. PLoS ONE 22, e7114 (2009).
  Google Scholar
• Abeliovich A. et al. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239–252 (2000).
  CAS PubMed Google Scholar
• Specht, C. G. & Schoepfer, R. Deletion of the α-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci. 2, 11 (2001).
  CAS PubMed PubMed Central Google Scholar
• Greten-Harrison, B. et al. αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proc. Natl Acad. Sci. USA 107, 19573–19578 (2010).
  CAS PubMed PubMed Central Google Scholar
• McCormack, A. L. et al. α-Synuclein suppression by targeted small interfering RNA in the primate substantia nigra. PLoS ONE 5, e12122 (2010).
  PubMed PubMed Central Google Scholar
• Lim, V. et al. α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J. Neurosci. 31, 10076–10087 (2011).
  CAS PubMed PubMed Central Google Scholar
• Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265–1269 (2000).
  CAS PubMed Google Scholar
• Giasson, B. I. et al. Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein. Neuron 34, 521–533 (2002).
  CAS PubMed Google Scholar
• Emmer, K. L., Waxman, E. A., Covey, J. P. & Giasson, B. I. E46K human α-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. J. Biol. Chem. 286, 35104–35118 (2011).
  CAS PubMed PubMed Central Google Scholar
• Lee, K. W. et al. Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model. J. Neurosci. 31, 6963–6971 (2012).
  Google Scholar
• Tofaris, G. K. et al. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein(1–120): implications for Lewy body disorders. J. Neurosci. 26, 3942–3950 (2006).
  CAS PubMed PubMed Central Google Scholar
• Garcia-Reitböck, P. et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 133, 2032–2044 (2010).
  PubMed PubMed Central Google Scholar
• Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301–1306 (2000).
  CAS PubMed Google Scholar
• Pan-Montojo, F. et al. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5, e8762 (2010).
  PubMed PubMed Central Google Scholar
• Kirik, D. et al. Parkinson-like neurodegeneration induced by targeted overexpression of α-synuclein in the nigrostriatal system. J. Neurosci. 22, 2780–2791 (2002).
  CAS PubMed PubMed Central Google Scholar
• Lo Bianco, C., Ridet, J. L., Schneider, B. L., Deglon, N. & Aebischer, P. α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc. Natl Acad. Sci. USA 99, 10813–10818 (2002).
  CAS PubMed PubMed Central Google Scholar
• Taschenberger, G. et al. Aggregation of α-synuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathol. 123, 671–683 (2012).
  CAS PubMed Google Scholar
• Burré, J., Sharma, M. & Südhof, T. C. Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities. J. Neurosci. 32, 15227–15242 (2012).
  PubMed PubMed Central Google Scholar
• Feany, M. B. & Bender, W. W. A Drosophila model of Parkinson's disease. Nature 404, 394–398 (2000).
  CAS PubMed Google Scholar
• Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M. & Bonini, N. M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865–868 (2002).
  CAS PubMed Google Scholar
• Periquet, M., Fulga, T., Myllykangas, L., Schlossmacher, M. G. & Feany, M. B. Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo. J. Neurosci. 27, 3338–3346 (2007).
  CAS PubMed PubMed Central Google Scholar
• Lakso, M. et al. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human α-synuclein. J. Neurochem. 86, 165–172 (2003).
  CAS PubMed Google Scholar
• Kuwahara, T. et al. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in α-synuclein transgenic C. elegans. Hum. Mol. Genet. 17, 2997–3009 (2007).
  Google Scholar
• Masuda, M. et al. Small molecule inhibitors of α-synuclein filament assembly. Biochemistry 45, 6085–6094 (2006).
  CAS PubMed Google Scholar
• Volpicelli-Daley, L. A. et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57–71 (2011).
  CAS PubMed PubMed Central Google Scholar
• Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl Acad. Sci. USA 106, 13010–13015 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hansen, C. et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest. 121, 715–725 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kordower, J. H. et al. Transfer of host-derived α-synuclein to grafted dopaminergic neurons in rat. Neurobiol. Dis. 43, 552–557 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mougenot, A. L. et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225–2228 (2012).
  CAS PubMed Google Scholar
• Luk, K. C. et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp. Med. 209, 975–986 (2012).
  CAS PubMed PubMed Central Google Scholar
• Masliah, E. et al. Effects of α-synuclein immunization in a mouse model of Parkinson's disease. Neuron 46, 857–868 (2005).
  CAS PubMed Google Scholar
• Masliah, E. et al. Passive immunization reduces behavioural and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS ONE 6, e19338 (2011).
  CAS PubMed PubMed Central Google Scholar
• Devine, M. J. et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat. Commun. 2, 440 (2011).
  PubMed Google Scholar
• Soldner, F. et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318–331 (2011).
  CAS PubMed PubMed Central Google Scholar
• Duffy, P. E. & Tennyson, V. M. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's disease. J. Neuropathol. Exp. Neurol. 24, 398–414 (1965).
  Google Scholar
• Parkinson, J. An Essay on the Shaking Palsy (Sherwood, Nealy and Jones, London, 1817).
  Google Scholar
• Charcot, J. M. Leçons sur les Maladies du Système Nerveux Vol. 1 (Delahaye et Cie, Paris, 1875).
  Google Scholar
• Von Economo, C. Die Encephalitis lethargica [German]. Wien. klin. Wochenschr. 30, 581–585 (1917).
  Google Scholar
• Vogt, C. & Vogt, O. Zur Lehre der Erkrankung des striären Systems [German]. J. Psychol. Neurol. 26, 43–57 (1920).
  Google Scholar
• Bradbury, S. & Eggleston, C. Postural hypotension: a report of three cases. Am. Heart J. 1, 75–86 (1925).
  Google Scholar
• Ehringer, H. & Hornykiewicz, O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems [German]. Klin. Wochenschr. 38, 1236–1239 (1960).
  CAS PubMed Google Scholar
• Birkmayer, W. & Hornykiewicz, O. Der L-Dioxyphenylalanineffekt bei der Parkinson-Akinese [German]. Wien. klin. Wochenschr. 73, 787–788 (1961).
  CAS PubMed Google Scholar
• Cotzias, G. C., Van Woert, M. H. & Schiffer, L. M. Aromatic amino acids and modification of parkinsonism. N. Engl. J. Med. 276, 374–379 (1967).
  CAS PubMed Google Scholar
• Hoehn, M. M. & Yahr, M. D. Parkinsonism: onset, progression and mortality. Neurology 17, 427–442 (1967).
  CAS PubMed Google Scholar
• Calne, D. B., Stern, G. M., Laurence, D. R., Sharkey, J. & Armitage, P. L-DOPA in postencephalitic parkinsonism. Lancet 1, 744–747 (1969).
  CAS PubMed Google Scholar
• Sacks, O. Awakenings (Duckworth, London, 1973).
  Google Scholar
• Ansari, K. A. & Johnson, A. J. Olfactory function in Parkinson's disease. J. Chronic Dis. 28, 493–497 (1975).
  CAS PubMed Google Scholar
• Kosaka, K., Oyanagi, S., Matsushita, M. & Hori, A. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes. Acta Neuropathol. 36, 221–233 (1976).
  CAS PubMed Google Scholar
• Langston, J. W., Ballard, P., Tetrud, J. & Irwin, I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979–980 (1983).
  CAS PubMed Google Scholar
• Qualman, S., Haupt, H. M., Yang, P. & Hamilton, S. D. Esophageal Lewy bodies associated with ganglion cell loss in achalasia: similarity to Parkinson's disease. Gastroenterology 87, 848–856 (1984).
  CAS PubMed Google Scholar
• Schenck, C. H., Bundle, S. R., Ettinger. M. G. & Mahowald, M. W. Chronic behavioural disorders of human REM sleep: a new category of parasomnia. Sleep 9, 293–308 (1986).
  CAS PubMed Google Scholar
• Benabid, A. L., Pollak, P., Louveau, A., Henry, S. & de Rougemont, J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl. Neurophysiol. 50, 344–346 (1987).
  CAS PubMed Google Scholar
• McKeith, I. G. et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47, 1113–1124 (1996).
  CAS PubMed Google Scholar
• Saiki, M. et al. Association of the human leucocyte antigen region with susceptibility to Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 81, 890–891 (2010).
  PubMed Google Scholar
• Braak, H. et al. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov. Disord. 21, 2042–2051 (2006).
  PubMed Google Scholar